3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
12
Stomach Neoplasms
4
Prostatic Neoplasms
4
Polycystic Ovary Syndrome
4
Neoplasms
3
Peripheral Nervous System Diseases
2
Lung Neoplasms
2
Inflammation
2
Esophageal Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Intraductal, Noninfiltrating
2
Weight Loss
1
Rectal Neoplasms
1
Psychological Well-Being
1
Psoriasis
1
Protein Deficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Obesity
1
Neoplasm, Residual
1
Multiple Sclerosis
1
Multiple Myeloma
1
Motor Activity
1
Malnutrition
1
Lipid Metabolism Disorders
1
Healthy Subject
1
Interventions
Etanercept
12
Adalimumab
12
Infliximab
7
golimumab
4
Tumor Necrosis Factor Inhibitors
4
Certolizumab Pegol
4
Abatacept
4
tofacitinib
2
tocilizumab
2
Rituximab
2
Antirheumatic Agents
2
Vitamin D
1
Vaccines
1
Syringes
1
Surveys and Questionnaires
1
Standard of Care
1
Sodium Chloride
1
Saline Solution
1
Radioimmunodetection
1
Prednisone
1
Practice Guidelines as Topic
1
Phlebotomy
1
Observation
1
Nivolumab
1
Methotrexate
1
Methods
1
Lysine Acetyltransferase 5
1
Licensure
1
Leflunomide
1
Interviews as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Arthritis, Rheumatoid
×
Fish Oils
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts